Been looking at healthcare diagnostics plays lately, and LH keeps popping up on my radar. Labcorp Holdings is one of those companies that doesn't get as much hype as some of the flashier growth stocks, but there's something solid here worth paying attention to.

So here's what caught my eye. LH is basically a leading diagnostics company based out of Burlington, NC - they handle clinical lab services and drug development support. They made a big move back in 2015 when they acquired Covance, which gave them serious capabilities in early and late-stage product development for pharma and biotech firms. That's a pretty strong moat.

Looking at the current setup, LH is trading at a forward P/E of 15.64, which is honestly pretty reasonable if you're into value investing. The stock has a VGM score of A and a Value score of B, which means it's hitting on multiple cylinders from a valuation perspective. That's not something you see every day.

What's interesting is the analyst activity. Four analysts bumped up their earnings estimates in the last 60 days for fiscal 2026, and the consensus estimate moved up to $17.65 per share. The stock also has a track record of beating expectations by about 3.1% on average, which suggests management knows how to execute.

I'm not saying LH is a home run, but it's the kind of stock that belongs on a watchlist if you're looking for something with real fundamentals backing it up. The valuation is attractive, the earnings momentum is positive, and it's not crowded with hype. Sometimes the best opportunities are the ones flying under the radar.

If you're browsing healthcare and diagnostics plays on Gate, LH might be worth a closer look.